Wedbush Starts Francesca's Holdings (FRAN) at Outperform; Unique Business Model & Impressive Store Rollout
Get Alerts FRAN Hot Sheet
Price: $2.22 --0%
Rating Summary:
9 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush initiates coverage on Francesca's Holdings (NASDAQ: FRAN) with a Outperform. PT $28.00.
Wedbush analyst says, "We believe the retailer’s differentiated mix of apparel, jewelry, accessories and gifting ideas, combined with uniqueness from a boutique atmosphere, is hard to replicate. In addition, we believe the company provides compelling growth and margin opportunities via (1) above average sq. ft. opportunities with strong store economics, (2) expansion of the nascent DTC channel, (3) a larger portion of sales from higher-margin jewelry/accessories/gifting ideas, and (4) scale and leverage on existing infrastructure."
For more ratings news on Francesca's Holdings click here and for the rating history of Francesca's Holdings click here.
Shares of Francesca's Holdings closed at $24.00 yesterday.
Wedbush analyst says, "We believe the retailer’s differentiated mix of apparel, jewelry, accessories and gifting ideas, combined with uniqueness from a boutique atmosphere, is hard to replicate. In addition, we believe the company provides compelling growth and margin opportunities via (1) above average sq. ft. opportunities with strong store economics, (2) expansion of the nascent DTC channel, (3) a larger portion of sales from higher-margin jewelry/accessories/gifting ideas, and (4) scale and leverage on existing infrastructure."
For more ratings news on Francesca's Holdings click here and for the rating history of Francesca's Holdings click here.
Shares of Francesca's Holdings closed at $24.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share